课题基金 / 基金详情

A study on expression and function of surface molecules of immunocompetent cells in rheumatoid arthritis.

A study on expression and function of surface molecules of immunocompetent cells in rheumatoid arthritis.
类风湿性关节炎免疫活性细胞表面分子表达及功能研究
批准号:
04670378
负责人:
INOUE Tetsufumi
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

INOUE Tetsufumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Expresssion of LFA-1, ICAM-1, and CD44 molecules on peripheral blood T lymphocytes were studied. No differences were found between RA patients and healthy individuals. Effects of several therapeutic drugs for RA on the expression of thode molecules were also analized. In the series of experiments, dexamethasone clearly decreased the expression of ICAM-1, suggesting the possibility that anti-rheumatic drugs showed their clinical effects through the modification on such molecules.Anti CD44 antibodies enhanced the release of IL-2 and IL-6 from activated T lymphocytes. Aggregation of cells by anti-CD44 antibodies was also observed in the culture, indicating that CD44 molecules showed the role of signal transmission through bringing T lymphocytes in contact with each other.IL-10 enhanced the proliferation and differentiation of activated B lymphocytes in the presence of IL-2, by means of the accelerated expression of IL-2 receptor molecules.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
S.Hirohta, S.Shinohara, T.Inoue, et.al.: "Regulation of B cell function by Lobenzarit, a novel disease-modifying antirheumatic drug." Arthritis Rheum.35. 168-175 (1992)
S.Hirohta、S.Shinohara、T.Inoue 等人:“Lobenzarit(一种新型缓解疾病抗风湿药物)对 B 细胞功能的调节”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Itoh, Y.Nishioka, T.Inoue, et.al.: "HIV induced systemic lupus erythematosus." Lupus. 3. 205-206 (1994)
K.Itoh、Y.Nishioka、T.Inoue 等人:“HIV 诱发的系统性红斑狼疮。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
HIROHATA,S.,SHINOHARA,S.,INOUE,T.,MIYAMOTO,T.,LIPSKY,P.: "REGULATION ON OF B CELL FUNCTION BY LOBENZARIT,A NOVEL DISEASE MODIFYING ANTIRHEMATIC DRUG." ARTHRITIS RHEUM.35. 168-175 (1992)
HIROHATA,S.、SHINOHARA,S.、INOUE,T.、MIYAMOTO,T.、LIPSKY,P.:“洛本扎利(一种新型抗病药物)对 B 细胞功能的调节。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
SHINOHARA,S.,HIROHATA,S.,INOUE,T.,ITO,K.: "PHENOTYPIC ANALYSIS OF PERIPHERAL BLOOD MONOCYTES ISOLATED FROM PATIENTS WITH RHEUMATOID ARTHRITIS." J.RHEUMATOL.19. 211-215 (1992)
Shinohara,S.、Hirohata,S.、Inoue,T.、ITO,K.:“从类风湿性关节炎患者中分离的外周血单核细胞的表型分析。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Inhibition of tumor necrosis factor (TNF)-α mediated IκB kinase activation in rheumatoid fibroblast-like synoviocytes in vitro and collagen-induced arthritis by a novel IKK-β inhibitor
    Molecular biological studies on the characterization of novel human endogenous retrovirus associated with autoimmune diseases.
    • 批准号:
      12670419
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      2000
    • 负责人:
      INOUE Tetsufumi
    • 依托单位:
    A study on altered immune function in rheumatoid arthritis through disfunction of transcription factor
    • 批准号:
      07807051
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1995
    • 负责人:
      INOUE Tetsufumi
    • 依托单位:
    The role of rheumatoid factor on altered immune responses of intra-articular lymhocytes in rheumatoid arthritis.
    • 批准号:
      01570354
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1989
    • 负责人:
      INOUE Tetsufumi
    • 依托单位:
    国内基金
    海外基金
    LRG1调控肝窦内皮细胞ICAM-1的表达介导中性粒细胞浸润促进脓毒症相关肝损伤的机制研究
    • 批准号:
      2026JJ81899
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      钟树武
    • 依托单位:
    梅 毒 螺 旋 体 膜 脂 蛋 白 Tpn32 经 ERK1/2-NF- κB 调 控 ICAM-1/LFA-1 促血管损伤机制研究
    • 批准号:
      2024JJ9412
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      黄洁丽 特
    • 依托单位:
    MMP-8调控ICAM-1表达引发中性粒细胞黏附在严重烧伤血管通透性增加中的作用和分子机制
    • 批准号:
      82302801
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      方晓
    • 依托单位:
    Mac-1/FAK/p38αMAPK在ICAM-1募集肿瘤相关巨噬细胞致肝癌不完全射频消融后血管通透性增加的机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      孔健
    • 依托单位: